Myocardial infarction: no clear association with elevated C.
pneumoniae IgG titres
|
|
|
Clinical bottom line (level 3b)
- Elevated Chlamydia pneumoniae IgG titres were not
clearly associated with an increased risk of cardiovascular
disease
| |
Danesh et al: BMJ 2000; 321 : 208-213
|
Expires February 2004
|
The study Case-control study with objective outcomes, adjusted for
confounding factors, validated in an independent set of patients.
Setting: 24 towns, UK
1533 patients (aged mean 52, 100%
male) Cases: 502 patients (100% male, mean age 52): death from
coronary heart disease or non-fatal myocardial infarction (based on WHO
criteria) Controls: 1029 patients (100% male, mean age 52): no
myocardial infarction: matched for town, and age
Factors studied:
- age, smoking, lipid levels, social class, martial status, father's
occupation
Factors summarised:
- elevated IgG to C. pneumoniae: top third v. controls
Outcomes
studied:
- cardiovascular death or non-fatal myocardial infarction
The evidence Patient expected event rate for cardiovascular death or
non-fatal myocardial infarction: 6.6%
risk factor for cardiovascular death or
non-fatal myocardial infarction |
adjusted OR (95% CI) |
NNH (95% CI) |
| elevated IgG to C. pneumoniae: |
1.22 (0.82 to 1.82) |
75 (-90 to 21) |
Comments
- The authors also combined their study with 14 other cohort studies
in a meta-analysis (not described in detail) and noted an odds ratio of
1.15 (95% CI: 0.95 to 1.41) with no significant heterogeneity.
Citation
- Danesh J, Whincup P, Walker M, et al: Chlamydia pneumoiae IgG titres
and coronary heart disease: prospective study and meta-analysis. BMJ
2000; 321 : 208-213
Search Terms: from ACP Journal Club other
articles noted Contributor: Chris Ball, February 2002 Reviewer:
Clinical Question.
| Patient |
male |
| Intervention or Exposure |
seropositive for Chlamydia pneumoniae |
| Outcome |
cardiovascular death or myocardial
infarction | |
|